Cytomegalovirus (CMV) Serostatus Reassessment in CMV Seronegative Kidney Transplant Candidates
Program adherence to CMV serostatus reassessment within 6 months of transplant was high in a clinical setting and identified a low incidence of seroconversion.
Authors
- Puneet Sood (ORCID: https://orcid.org/0000-0002-0503-4707)
- Monica Fung (ORCID: https://orcid.org/0000-0002-1725-5259)
- Lakshin Kumar
- Anna Mello
- Garrett R. Roll
- Ajmeet K. Pama‐Ghuman
- Ajit P. Limaye
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1111/tid.70150
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00